We treated two pancreatic cancer cell lines (Miapaca2, PDA) and lung cancer cell lines (H1299, H460) with the PARP inhibitor, LT626 (0–10 μM) for five days and cell viability was measured by MTT assay. The gene discussed is PARP1; the disease is familial pancreatic carcinoma.